These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26869515)

  • 1. Ethyl-2, 5-dihydroxybenzoate displays dual activity by promoting osteoblast differentiation and inhibiting osteoclast differentiation.
    Kwon BJ; Lee MH; Koo MA; Kim MS; Seon GM; Han JJ; Park JC
    Biochem Biophys Res Commun; 2016 Mar; 471(3):335-41. PubMed ID: 26869515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethyl-3,4-dihydroxybenzoate with a dual function of induction of osteogenic differentiation and inhibition of osteoclast differentiation for bone tissue engineering.
    Kwon BJ; Lee MH; Koo MA; Han JJ; Park JC
    Tissue Eng Part A; 2014 Nov; 20(21-22):2975-84. PubMed ID: 24784993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic.
    Zhang S; Feng P; Mo G; Li D; Li Y; Mo L; Yang Z; Liang D
    Biomed Pharmacother; 2017 Apr; 88():436-442. PubMed ID: 28122309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk of osteoblast and osteoclast precursors on mineralized collagen--towards an in vitro model for bone remodeling.
    Bernhardt A; Thieme S; Domaschke H; Springer A; Rösen-Wolff A; Gelinsky M
    J Biomed Mater Res A; 2010 Dec; 95(3):848-56. PubMed ID: 20824694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic silica/apatite co-mineralized collagen scaffolds stimulate osteogenesis and inhibit RANKL-mediated osteoclastogenesis.
    Jiao K; Niu LN; Li QH; Chen FM; Zhao W; Li JJ; Chen JH; Cutler CW; Pashley DH; Tay FR
    Acta Biomater; 2015 Jun; 19():23-32. PubMed ID: 25792280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-2 Derived Peptide and Dexamethasone Incorporated Mesoporous Silica Nanoparticles for Enhanced Osteogenic Differentiation of Bone Mesenchymal Stem Cells.
    Zhou X; Feng W; Qiu K; Chen L; Wang W; Nie W; Mo X; He C
    ACS Appl Mater Interfaces; 2015 Jul; 7(29):15777-89. PubMed ID: 26133753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eluted zinc ions stimulate osteoblast differentiation and mineralization in human dental pulp stem cells for bone tissue engineering.
    Yusa K; Yamamoto O; Iino M; Takano H; Fukuda M; Qiao Z; Sugiyama T
    Arch Oral Biol; 2016 Nov; 71():162-169. PubMed ID: 27521529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of extracellular magnesium extract on the proliferation and differentiation of human osteoblasts and osteoclasts in coculture.
    Wu L; Feyerabend F; Schilling AF; Willumeit-Römer R; Luthringer BJC
    Acta Biomater; 2015 Nov; 27():294-304. PubMed ID: 26318802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-amino acid inhibits biofilm but not new bone formation in an ovine model.
    Harmata AJ; Ma Y; Sanchez CJ; Zienkiewicz KJ; Elefteriou F; Wenke JC; Guelcher SA
    Clin Orthop Relat Res; 2015 Dec; 473(12):3951-61. PubMed ID: 26201421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal enterotoxin C2 promotes osteogenesis and suppresses osteoclastogenesis of human mesenchymal stem cells.
    Fu WM; Zhu X; Wang H; Wei-Mao Wang ; Chen JY; Liang Y; Zhang JF; Kung HF
    Exp Cell Res; 2014 Mar; 322(1):202-7. PubMed ID: 24355808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells.
    Satué M; Arriero Mdel M; Monjo M; Ramis JM
    Biochem Pharmacol; 2013 Nov; 86(10):1476-86. PubMed ID: 24060614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic and osteoclastogenic differentiation of co-cultured cells in polylactic acid-nanohydroxyapatite fiber scaffolds.
    Morelli S; Salerno S; Holopainen J; Ritala M; De Bartolo L
    J Biotechnol; 2015 Jun; 204():53-62. PubMed ID: 25858154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro.
    Ming LG; Lv X; Ma XN; Ge BF; Zhen P; Song P; Zhou J; Ma HP; Xian CJ; Chen KM
    Endocrinology; 2013 Mar; 154(3):1202-14. PubMed ID: 23389955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
    Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
    J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.